EUVIMEDEUVIMED entdecken
Crossref

Comparing the Outcomes of Pediatric Liver Transplantation

Kamil Yalçın Polat, Şerafettin Yazar, Serdar Aslan, Ahmet Kargı, Ayşe Selimoğlu, Bünyamin Gürbulak, İbrahim Astarcıoğlu

Transplantation Proceedings · 2023

DOI: 10.1016/j.transproceed.2023.05.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2023. Verfasst von Kamil Yalçın Polat und 6 weiteren Autor:innen. Beteiligte Einrichtung: Organ Transplantation Center, Bahçelievler Memorial Hospital, Istanbul, Turkey. Hauptthemen laut MEDLINE: Liver Transplantation, Liver Failure. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Liver transplantation is a life-saving treatment for end-stage pediatric liver failure. We aimed to present the results of pediatric liver transplants performed in our center in the last 11 years (between 2012 and March 2022) in association with prognostic factors affecting survival. METHODS: Demographic characteristics, etiologic reasons, previous operations (Kasai procedure), morbidity, mortality, survival, and bilio-vascular complication rates were determined, and outcomes were evaluated. In the postoperative period, the duration of mechanical ventilation and intensive care unit stay and surgical and other complications were evaluated. Graft and patient survival rates were determined, and univariate and multivariate factors affecting these rates were evaluated. RESULTS: In the last 10 years, 229 pediatric liver transplantaion (Pe-LT)/1513 adult liver taransplantation (Ad-LT) (21.35%) were performed in our center. This ratio (Pe-LT/Ad-LT ratio) is 1741/15,886 (10.95%) for our country. A total of 229 liver transplants were performed in 214 pediatric patients. Retransplantation was performed in 15 patients (6.55%). Cadaveric liver transplantation was performed in 9 patients. Graft survival rates were 87%, 83%, 78%, 78%, 78%, and 78% at 3 years, respectively. Patient survival rates for 3 years were 91.5%, 85.7%, 82%, 81.5%, and 81.5%, respectively. Our 5-year survival rates in metabolic diseases and the acute fulminant failure group are 93.8% and 100%, respectively. CONCLUSIONS: The fact that the 1- and 5-year survival rates are the same shows that when patients overcome biliary vascular and infectious problems, their survival is prolonged.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationLiver FailureAdultHumansChildPortoenterostomy, HepaticReoperationSurvival RateGraft SurvivalTreatment OutcomeRetrospective StudiesPostoperative Complications

Autor:innen und Institutionen

  • Organ Transplantation Center, Bahçelievler Memorial Hospital, Istanbul, Turkey.
  • Department of Pediatric Gastroenterology, Bahçelievler Memorial Hospital, Istanbul, Turkey.
  • Organ Transplantation Center, Bahçelievler Memorial Hospital, Istanbul, Turkey. Electronic address: bgurbulak@gmail.com.

Zitieren

APA

Polat, K. Y., Yazar, Ş., Aslan, S., Kargı, A., Selimoğlu, A., Gürbulak, B., & Astarcıoğlu, İ. (2023). Comparing the Outcomes of Pediatric Liver Transplantation. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2023.05.004

Vancouver

Polat KY, Yazar Ş, Aslan S, Kargı A, Selimoğlu A, Gürbulak B, et al. Comparing the Outcomes of Pediatric Liver Transplantation. Transplantation Proceedings. 2023. doi:10.1016/j.transproceed.2023.05.004

BibTeX
@article{Polat2023,
  author = {Polat, Kamil Yalçın and Yazar, Şerafettin and Aslan, Serdar and Kargı, Ahmet and Selimoğlu, Ayşe and Gürbulak, Bünyamin and Astarcıoğlu, İbrahim},
  title = {Comparing the Outcomes of Pediatric Liver Transplantation},
  journal = {Transplantation Proceedings},
  year = {2023},
  doi = {10.1016/j.transproceed.2023.05.004}
}
Kostenlos starten →